NeoGenomics (NEO) Reports Q1 2026 Earnings with Revenue Growth and Margin Expansion

NeoGenomics (NEO) reported Q1 2026 earnings with total revenue of $186.7 million, exceeding guidance and showing 11% year-over-year growth. Clinical revenue grew 14% driven by higher volumes and pricing, while NGS revenue surged 26%. Adjusted EBITDA rose 27% to $9 million, with margin expansion of 60 basis points.

By Motley Fool Transcribing · Motley Fool · April 28, 2026, 21:52 UTC

Tickers: $NEO

Topics: cash position clinical revenue earnings EBITDA NGS revenue operational expenses revenue growth

Read the full article at Motley Fool

More World news

Nvidia CEO Jensen Huang Resigns Amid Investigation and Personal Allegations Motley Fool · November 12, 2026, 17:20 UTC
Argus Research Upgrades Republic Services to Buy Seeking Alpha · November 12, 2026, 17:16 UTC
Moderna Shares Decline Following Analyst Day Projections and Future Cost Concerns Motley Fool · November 12, 2026, 17:13 UTC
United Airlines Restricts AI Agent Access to Booking Systems Due to Cybersecurity and Regulatory Concerns TechCrunch · November 12, 2026, 17:17 UTC
Global Payments Shares Drop 12% Following Reports Private Equity Firms Abandoned Takeover Bid Seeking Alpha · November 12, 2026, 17:14 UTC
Nvidia Appoints Colette Kress as Interim CEO Following Jensen Huang's Resignation CNBC · November 12, 2026, 16:59 UTC
Brookfield Corporation Reports Strong Third Quarter Earnings Growth and Increased Share Buybacks Motley Fool · November 12, 2026, 17:08 UTC
Franco-Nevada Reports Q3 2026 Revenue Growth Driven by Higher Gold and Oil Prices Motley Fool · November 12, 2026, 17:10 UTC
Stratasys Reports Q3 2026 Revenue Growth Driven by Aerospace and Defense Demand Motley Fool · November 12, 2026, 17:11 UTC
Jim Cramer Advises Profit-Taking Following Jensen Huang's Resignation at Nvidia CNBC · November 12, 2026, 16:59 UTC